<DOC>
	<DOCNO>NCT01412437</DOCNO>
	<brief_summary>The investigator use different type brain imaging ( MRI ) patient Phenylketonuria ( PKU ) currently strict diet test hypothesis improvement brain circuitry biochemistry return diet and/or sapropterin dihydrochloride ( Kuvan ) .</brief_summary>
	<brief_title>Neuroimaging Neurocognitive Assessment Response Sapropterin Dihydrochloride Treatment Phenylketonuria</brief_title>
	<detailed_description>We plan enroll 36 subject PKU . They counsel follow PKU diet . They randomize receive Kuvan . We plan enroll 12 diet alone group 24 Kuvan group hope 12 responder ( define 30 % drop blood phe level ) . Those blood response decrease Phe still evaluate neurological response measure neurocognitive test neuroimaging outline protocol . All 24 Kuvan group receive 1 month trial Kuvan responder insurance cover drug non responder Biomarin supply Kuvan . Aim 1 : To test hypothesis stable patient PKU currently diet specific brain biomarkers quantifiable DTI , fMRI MRS level biomarkers correlate clinical severity outcome . Our pilot study research others suggest follow potential biomarkers neural injury PKU : - Metabolic abnormality : elevate Phe concentration measure MRS. - White matter microstructure : measure apparent diffusion coefficient , ( ADC ) , use DTI . - Working memory attention/executive function : measure fMRI , Near infrared spectroscopy ( NIRS ) neuropsychological test . We study potential biomarkers group well characterize adult PKU currently diet strict diet evidence elevated Phe , identify newborn screen may diet childhood , vary severity clinical involvement . Aim 2 : To measure change biomarkers validate Aim 1 return diet +/- Kuvan ( sapropterin dihydrochloride ; Kuvan ) Based preliminary data others , Aim 1 provide u number candidate biomarkers brain injury PKU . We expect include three type marker correlate : metabolic , structural cognitive . We use biomarkers study subject return diet and/or initiation Kuvan . Aim 3 : To compare cognitive performance subject prior return diet +/- Kuvan . use follow test : Comprehensive Trail make test ( CTMT ) -Parts A B Stroop WASI ( IQ , digit span ) BRIEF Edinburgh Handedness Inventory Hand Preference Demonstration Test Outcome variables The primary endpoint study 1 ) estimate white matter damage ( macroscopic microscopic ) participant PKU versus control baseline return diet +/- Kuvan ; 2 ) determination profile brain biochemical abnormality participant PKU versus control baseline return diet/Kuvan , 3 ) assessment cognitive motor system abnormality ( fMRI cognitive testing ) participant cohort compare age match typically develop non disease control baseline return diet/Kuvan ; 4 ) coefficient variability score traditional neurocognitive . After conclusion study , future area research would include expansion study long term effect Kuvan , study impair population response Kuvan , use optical image method currently pilot OTCD . Method investigate biomarkers disease We plan use 1HMRS identify marker disease severity elevation Phe decrease NAA . This compare participant normal age match control . Additionally , diffusion tensor image allow u probe white matter fiber tract may especially vulnerable disorder selectively . Lastly , fMRI may identify region differential activation brain different participant versus age match control rest cognitive task probe work memory attention .</detailed_description>
	<mesh_term>Phenylketonurias</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<criteria>1 . Patients PKU identify Newborn screen phe concentration &gt; 12mg/dl newborn screen 2 . Baseline phe level study enrollment &gt; 20 mg/dl ( level require inclusion study , regardless level use make diagnosis ) 3 . Age range : 1845 year 4 . Able comply neuroimaging without require sedation ( typically require IQ 65 ) . The IQ check WASI ( Weschler Adult scale intelligence ) determine eligibility 5 . Able undergo neuroimaging safely ( i.e . without presence ferromagnetic device ) 6 . Subject ability follow instruction English 7 . Female childbearing age sexually active agrees urine pregnancy test 8 . Availability come Washington , DC participate study 1 . Age range &lt; 18 &gt; 45 year 2 . Inability comply neuroimaging without use sedation ( low IQ claustrophobic ) 3 . Presence ferromagnetic device ( ) preclude safe image include cardiac pacemaker , neural pacemaker , surgical clip brain blood vessel , surgically implant metal plate , screw pin , cochlear implant metal object body 4 . Pregnant female breastfeed screen plan become pregnant time study . 5 . Baseline phe &lt; 20 mg/dl 6 . Currently Kuvan 7 . History substance abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>PKU</keyword>
	<keyword>MRI</keyword>
	<keyword>neurocognition</keyword>
	<keyword>sapropterin dihydrochloride</keyword>
</DOC>